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OBJECTIVE
In order to follow and understand epidemiological changes and to provide information related to capsular types to include 




From January 1998 to December 2007, laboratories belonging to the 
Belgian surveillance network, sent to the National reference centre for 
GBS, a total of 1021 (80-122/year) clinically significant strains of GBS.   
A description of these isolates is given in the following table: 300 GBS 
were recovered from neonates’ blood, cerebro-spinal fluid or any deep 
site, and 721 isolates were recovered from adults with severe 
infections.
Description of 1021 strains of GBS isolated from invasive disease: age groups 
and diagnostics (01.1998-12.2007, Belgium).
Serotyping
Upon receipt, isolates were confirmed as belonging to group B.  
Serotyping was then performed by a coagglutination latex method.
From 1998 to 2004, the GBS serotyping Test (ESSUM, Denmark) was 
used.  The typing set included reagents specific for polysaccharidic
antigens Ia, Ib to V.
From 2005 to 2007, the Strep-B-latex kit from the Statens Serum 
Institute (SSI, Denmark) was used and allowed typing of serotypes Ia, 
Ib to VIII.
RESULTS
Distribution (%) of serotypes of GBS isolated in Belgium from different 
groups of patients, from 1998 trough 2007.
Annual distribution of serotypes of GBS isolated from neonatal EOD.
Annual distribution of serotypes of GBS isolated from neonatal LOD.
Annual distribution of serotypes of GBS isolated from non-pregnant adults.
BACKGROUND:
Group B streptococcus (GBS) continue to be a major cause of life-threatening infections, sepsis, pneumonia and meningitis in 
neonates. Pregnant women and non-pregnant adults are also affected by severe GBS diseases. In the last decades, capsular serotypes 
Ia, Ib, II and III caused the majority of diseases.  Their distribution varies according to time and geographic locations.  For 
epidemiological purpose as well as for  the development and formulation of GBS vaccines, ongoing surveillance of GBS serotype 
distribution is critical.
CONCLUSION
 Distributions of GBS serotypes varied by patient’s age-groups
 Serotype III remained the major serotype in neonatal infections
and particularly in LOD. As in adults infections, diversity of serotypes 
was observed in EOD.
 Adult’s distribution of GBS serotypes: Ia, III and V, were the  
predominant serotypes, but Ib, II and IV were also well represented.
 A relative increase of serotype V. Either in adult’s distribution or in 
the distribution of isolates from neinatal EOD, through the decade, 
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